Insys Therapeutics (INSY)

8.24 +0.37 (4.70%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/2/18 *Est.)

Latest Headlines

INSYS Therapeutics Provides an Update on Its Ongoing Transformation June 18, 2018 12:58 PM - Globe NewsWire Insys Therapeutics (INSY) Jumps as Epinephrine Nasal Spray Shows Early Promise for Anaphylaxis June 14, 2018 1:06 PM - StreetInsider Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection June 14, 2018 8:00 AM - Globe NewsWire INSYS Therapeutics to Present at Jefferies Global Healthcare Conference June 4, 2018 4:15 PM - Globe NewsWire Minnesota sues opioid maker Insys over improper drug marketing May 30, 2018 12:24 PM - StreetInsider Insys Therapeutics (INSY) Confirms FDA Panel on Buprenorphine Voted Not to Recommend Approval May 22, 2018 3:09 PM - StreetInsider INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray May 22, 2018 3:08 PM - Globe NewsWire Pre-Open Movers 05/18: (QTNT) (AFSI) (CERN) Higher; (AGRX) (ARQL) (CPB) Lower (more...) May 18, 2018 9:28 AM - StreetInsider FDA Posts Briefing Documents Ahead of Review of Insys Therapeutics' (INSY) BSS May 18, 2018 9:07 AM - StreetInsider Insys Therapeutics (INSY) Comments on Unsealing of Previously Filed Qui Tam Complaints and Recaps Transformation Efforts May 15, 2018 12:23 PM - StreetInsider INSYS Therapeutics Responds to Unsealing of Previously Filed Qui Tam Complaints and Recaps Transformation Efforts May 15, 2018 12:22 PM - Globe NewsWire U.S. and 5 States Add Their Support to Lawsuit Filed by The Employment Law Group against Insys Therapeutics May 14, 2018 6:01 PM - BizWire Form 4 Insys Therapeutics, Inc. For: Feb 21 Filed by: Tambi Brian May 14, 2018 5:51 PM - SEC Filing Form 10-Q Insys Therapeutics, Inc. For: Mar 31 May 10, 2018 5:13 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: May 08 Filed by: Vishnoi Rohit May 10, 2018 2:56 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Feb 21 Filed by: LAPALME PIERRE May 10, 2018 2:55 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Feb 21 Filed by: MEYER STEVEN J May 10, 2018 2:54 PM - SEC Filing INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East May 8, 2018 4:02 PM - Globe NewsWire Insys Therapeutics (INSY) Misses Q1 EPS by 1c May 8, 2018 4:01 PM - StreetInsider INSYS Therapeutics Reports First Quarter 2018 Results May 8, 2018 4:00 PM - Globe NewsWire Fresenius alleges 'blatant fraud' at U.S. drugmaker Akorn May 2, 2018 11:36 AM - StreetInsider Form DEFA14A Insys Therapeutics, Inc. May 1, 2018 6:44 AM - SEC Filing Insys Therapeutics (INSY) Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome April 27, 2018 8:07 AM - StreetInsider INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome April 27, 2018 8:00 AM - Globe NewsWire INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial April 26, 2018 8:00 AM - Globe NewsWire INSYS Therapeutics to Report First Quarter 2018 Results on May 8 April 25, 2018 6:00 AM - Globe NewsWire Insys Therapeutics (INSY) Reports Plan to Advance Clinical Research of Dronabinol Inhalation April 18, 2018 8:35 AM - StreetInsider INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device April 18, 2018 8:30 AM - Globe NewsWire Form 4 Insys Therapeutics, Inc. For: Apr 17 Filed by: Motahari Saeed April 17, 2018 2:27 PM - SEC Filing Form DEF 14A Insys Therapeutics, Inc. For: May 04 April 16, 2018 4:29 PM - SEC Filing Form 8-K Insys Therapeutics, Inc. For: Apr 02 April 2, 2018 1:28 PM - SEC Filing INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors April 2, 2018 8:30 AM - Globe NewsWire Full Article List